SK

Subir Kumar Mondal

Active Director Director DIN 06855559
DIN 06855559 First appointment May 2014 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since May 2014
Shareholding value •••• Premium profile

About Subir Kumar Mondal

Data last updated:

Subir Kumar Mondal is a Director at Unihelix Biotech Private Limited (since 2014), Director at Medidawn Life Science Private Limited (since 2019) and Director at Nextend Business Solutions Private Limited (since 2020). The companies operate in Pharma, Chemicals and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹2.30 Cr; the largest is Unihelix Biotech Private Limited at ₹1.49 Cr (FY 2025). Earlier, Subir Kumar Mondal was a Director at Mediclock Lifescience Private Limited (2018–2019).

DIN 06855559
Primary Designation Director
Industry Pharma
First Appointment 09 May 2014
Oldest Company Age 12 yrs
Largest company Unihelix Biotech Private Limited · ₹1.49 Cr (FY 2025)
Combined revenue ₹2.30 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Unihelix Biotech Private Limited U24100WB2014PTC201749
Director09 May 20142014₹1.49 Cr (FY 2025)Active
Director19 Nov 20192019₹80.6 Lakh (FY 2025)Active
Director14 Aug 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Nov 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Unihelix Biotech Private Limited
Medidawn Life Science Private Limited
Nextend Business Solutions Private Limited
Mediclock Lifescience Private Limited
Premium access

Shareholding and investment profile for Subir Kumar Mondal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Subir Kumar Mondal

Subir Kumar Mondal currently holds 3 directorships: Unihelix Biotech Private Limited (Director, since 09 May 2014, revenue ₹1.49 Cr (FY 2025)); Medidawn Life Science Private Limited (Director, since 19 Nov 2019, revenue ₹80.6 Lakh (FY 2025)); Nextend Business Solutions Private Limited (Director, since 14 Aug 2020).

Subir Kumar Mondal was first appointed on 09 May 2014 as Director at Unihelix Biotech Private Limited. The most recent appointment on record is 14 Aug 2020 at Nextend Business Solutions Private Limited.

The 2 current companies of Subir Kumar Mondal that report revenue have a combined latest revenue of ₹2.30 Cr: Unihelix Biotech Private Limited ₹1.49 Cr (FY 2025); Medidawn Life Science Private Limited ₹80.6 Lakh (FY 2025).

Subir Kumar Mondal held 1 earlier board appointment: Mediclock Lifescience Private Limited (Director, 20 Nov 2018 to 19 Jul 2019).

The current boards of Subir Kumar Mondal's companies include Bhairab Banerjee (Unihelix Biotech Private Limited), Indra Narayan Palit (Unihelix Biotech Private Limited), Ranajit Konar (Unihelix Biotech Private Limited), Sandip Ghosh (Unihelix Biotech Private Limited), Sankar Dhar (Unihelix Biotech Private Limited), Mrinmoyee Palit (Medidawn Life Science Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available